Case-Control Studies Diet/adverse effects *Diet Mediterranean Humans Incidence Rare Diseases Risk Factors *Urinary Bladder Neoplasms/epidemiology/etiology Bladder Cancer Dietary Inflammatory Index Mediterranean Diet Meta-analysis Western Diet

Animals *Cheese Cohort Studies Dairy Products Diet Humans Milk Risk Factors *Urinary Bladder Neoplasms/epidemiology/etiology Yogurt

Animals Body Mass Index Case-Control Studies Cohort Studies Dairy Products/*statistics & numerical data Diet/methods Educational Status Feeding Behavior Female Humans Male Milk/*statistics & numerical data Risk Factors Smoking/epidemiology Urinary Bladder Neoplasms/*epidemiology

Adult Female *Hormones/adverse effects Humans Menopause Middle Aged Prospective Studies *Reproductive History Risk Factors *Urinary Bladder Neoplasms/epidemiology Bladder cancer Health Study Nurses’ females hormones reproductive factors

Disease-Free Survival *Dose Fractionation Radiation Humans Neoplasm Recurrence Local/epidemiology/pathology/*radiotherapy Radiation Dose Hypofractionation/*standards Risk Factors Treatment Outcome Urinary Bladder Neoplasms/epidemiology/pathology/*radiotherapy

Administration Intravesical Antineoplastic Agents/*administration & dosage/adverse effects Clinical Trials as Topic Disease Progression Humans Neoplasm Metastasis *Neoplasm Recurrence Local Network Meta-Analysis Progression-Free Survival Risk Assessment Risk Factors Time Factors Urinary Bladder Neoplasms/*drug therapy/mortality/pathology

Aged *Diet Dietary Fiber/*administration & dosage Female Humans Male Middle Aged Prospective Studies Risk Factors Urinary Bladder Neoplasms/*prevention & control *Whole Grains bladder cancer cohort study dietary fiber dose-response analysis grain

Age of Onset Cohort Studies Female Hormones/*metabolism Humans Menopause Middle Aged Parity Prospective Studies *Reproduction Risk Assessment Risk Factors United States/epidemiology Urinary Bladder Neoplasms/epidemiology/*physiopathology Plco bladder cancer hormones meta-analysis reproductive factors interest.

Adult Caffeine/*adverse effects Central Nervous System Stimulants/adverse effects Coffee/*adverse effects Cytochrome P-450 CYP1A2 Dose-Response Relationship Drug Female Humans Male Middle Aged Risk Factors Smoking/*adverse effects Urinary Bladder Neoplasms/*etiology Bladder cancer Coffee consumption Cohort study Dose–response analyses Smoking

Cystectomy/adverse effects Humans Postoperative Complications/diagnosis/epidemiology/etiology Risk Factors *Robotic Surgical Procedures/adverse effects *Robotics Treatment Outcome *Urinary Bladder Neoplasms/surgery Urologic Surgical Procedures *Urology Complications European Association of Urology guidelines Outcome reporting Robot-assisted radical cystectomy Standardised tool

Humans Incidence Risk Factors Suicide/*statistics & numerical data Urinary Bladder Neoplasms/diagnosis/*psychology Bladder cancer Meta-analysis Suicide Systematic review

Antihypertensive Agents/*adverse effects/therapeutic use Disease Susceptibility Dose-Response Relationship Drug Humans Hypertension/complications/drug therapy/etiology Kidney Neoplasms/*epidemiology/*etiology Odds Ratio Publication Bias Risk Assessment Risk Factors Urinary Bladder Neoplasms/*epidemiology/*etiology antihypertensive medications bladder cancer kidney cancer meta-analysis risk interest.

Adjuvants Immunologic Cystectomy Humans *Kidney Transplantation/adverse effects Risk Factors *Urinary Bladder Neoplasms/epidemiology Bcg Bladder cancer Cáncer vesical Kidney transplantation Trasplante renal

Carcinoma Transitional Cell/diagnosis/epidemiology/*therapy Child Combined Modality Therapy *Disease Management Disease Progression Global Health Humans Incidence Risk Factors Survival Rate/trends Urinary Bladder/*pathology Urinary Bladder Neoplasms/diagnosis/epidemiology/*therapy Management Pediatric Surveillance Transurethral resection Urothelial cell carcinoma

Adult Aged Air Pollution/*adverse effects Carcinogens Environmental/*adverse effects Cohort Studies Environmental Exposure/*adverse effects Europe/epidemiology Female Humans Incidence Male Meta-Analysis as Topic Middle Aged Nitrogen Oxides/adverse effects Particulate Matter/adverse effects Prospective Studies Risk Factors Urinary Bladder Neoplasms/*epidemiology/etiology Air pollution Bladder cancer Environment Prevention

Carcinoma Papillary/mortality/pathology/*therapy Disease Progression Humans Neoplasm Staging Progression-Free Survival Risk Assessment Risk Factors Time Factors Urinary Bladder Neoplasms/mortality/pathology/*therapy Urothelium/*pathology Bacillus Calmette-Guérin therapy Bladder cancer Bladder sparing Immediate cystectomy Micropapillary Prognosis Transurethral resection Urothelial carcinoma Variant histology

25-Hydroxyvitamin D3 1-alpha-Hydroxylase/metabolism Cell Line Tumor Humans Receptors Calcitriol/metabolism Risk Factors Signal Transduction Urinary Bladder Neoplasms/*blood/etiology/metabolism Vitamin D/*analogs & derivatives/blood/metabolism Vitamin D Deficiency/*blood/complications/metabolism 1 25(oh)(2)d 1α-hydroxylase Bladder cancer Cathelicidin Vitamin D

Blood Loss Surgical/statistics & numerical data Blood Transfusion/statistics & numerical data Cystectomy/*adverse effects/methods Hospital Mortality Humans Length of Stay/statistics & numerical data Operative Time Postoperative Complications/*epidemiology/etiology Quality of Life Risk Factors Robotic Surgical Procedures/*adverse effects Treatment Outcome Urinary Bladder/surgery Urinary Bladder Neoplasms/*surgery Urinary Diversion/*adverse effects/methods health-related quality of life meta-analysis open radical cystectomy postoperative complication robot-assisted radical cystectomy

Diabetes Mellitus Type 2/*drug therapy Dose-Response Relationship Drug Humans Hypoglycemic Agents/*adverse effects Incidence Observational Studies as Topic Pioglitazone/*adverse effects Risk Factors Urinary Bladder Neoplasms/*chemically induced

Diabetes Mellitus Type 2/complications/drug therapy Humans Hypoglycemic Agents/*adverse effects/therapeutic use Odds Ratio Pioglitazone/*adverse effects/therapeutic use Randomized Controlled Trials as Topic Risk Assessment Risk Factors Time Factors Urinary Bladder Neoplasms/*etiology Bladder cancer dose-response relationship meta-analysis pioglitazone